Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric So

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Science Translational Medicine|February 25, 2021
Functional reconstruction of human AML reveals stem cell origin and vulnerability of treatment-resistant MLL-rearranged leukemiaBernd B Zeisig, Tsz Kan Fung, Magdalena Zarowiecki, et al.
Cancer Cell|December 2, 2019
HOTTIP lncRNA Promotes Hematopoietic Stem Cell Self-Renewal Leading to AML-like Disease in MiceHuacheng Luo, Ganqian Zhu, Jianfeng Xu, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Discovery of Reversible Inhibitors of KDM1A Efficacious in Acute Myeloid Leukemia ModelsAlessia Romussi, Anna Cappa, Paola Vianello, et al.
Molecular Cell|February 18, 2022
HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemiaHuacheng Luo, Ganqian Zhu, Melanie A Eshelman, et al.
The Journal of Experimental Medicine|December 9, 2015
Hif-1α and Hif-2α synergize to suppress AML development but are dispensable for disease maintenanceMilica Vukovic, Amelie V Guitart, Catarina Sepulveda, et al.
EMBO Molecular Medicine|August 9, 2020
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemiaBai-Liang He, Ning Yang, Cheuk Him Man, et al.
EMBO Molecular Medicine|March 6, 2020
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemiaBai-Liang He, Ning Yang, Cheuk Him Man, et al.
Blood|June 25, 2025
Transposable elements as novel therapeutic targets for PARPi-induced synthetic lethality in PcG-mutated blood cancerBernd Zeisig, Chiou-Tsun Tsai, Clemence Virely, et al.
Blood|September 22, 2023
Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AMLCheuk-Him Man, Wing Lam, Chee-Chean Dang, et al.
Science Translational Medicine|October 7, 2016
Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemiaStephen S Y Lam, Eric S K Ho, Bai-Liang He, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Science Translational Medicine|February 25, 2021
Functional reconstruction of human AML reveals stem cell origin and vulnerability of treatment-resistant MLL-rearranged leukemiaBernd B Zeisig, Tsz Kan Fung, Magdalena Zarowiecki, et al.
Cancer Cell|December 2, 2019
HOTTIP lncRNA Promotes Hematopoietic Stem Cell Self-Renewal Leading to AML-like Disease in MiceHuacheng Luo, Ganqian Zhu, Jianfeng Xu, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Discovery of Reversible Inhibitors of KDM1A Efficacious in Acute Myeloid Leukemia ModelsAlessia Romussi, Anna Cappa, Paola Vianello, et al.
Molecular Cell|February 18, 2022
HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemiaHuacheng Luo, Ganqian Zhu, Melanie A Eshelman, et al.
The Journal of Experimental Medicine|December 9, 2015
Hif-1α and Hif-2α synergize to suppress AML development but are dispensable for disease maintenanceMilica Vukovic, Amelie V Guitart, Catarina Sepulveda, et al.
EMBO Molecular Medicine|August 9, 2020
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemiaBai-Liang He, Ning Yang, Cheuk Him Man, et al.
EMBO Molecular Medicine|March 6, 2020
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemiaBai-Liang He, Ning Yang, Cheuk Him Man, et al.
Blood|June 25, 2025
Transposable elements as novel therapeutic targets for PARPi-induced synthetic lethality in PcG-mutated blood cancerBernd Zeisig, Chiou-Tsun Tsai, Clemence Virely, et al.
Blood|September 22, 2023
Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AMLCheuk-Him Man, Wing Lam, Chee-Chean Dang, et al.
Science Translational Medicine|October 7, 2016
Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemiaStephen S Y Lam, Eric S K Ho, Bai-Liang He, et al.
Pageof 11